Literature DB >> 15028319

Outcomes of surgery for dermatofibrosarcoma protuberans.

C K Chang1, I A Jacobs, G I Salti.   

Abstract

BACKGROUND: Dermatofibrosarcoma protuberans (DFSP) is a rare soft tissue sarcoma usually presenting as nodular cutaneous mass on the trunk and proximal extremity. The tumour grows slowly, typically over years. The standard treatment is wide local excision with at least a 3-cm margin. The local regional recurrence is up to 50%, emphasizing the need for wide margins for local control. A small fraction of DFSP may metastasize, but on histological examination such tumours have features of fibrosarcomas rather than DFSP. HYPOTHESIS: This study was done to review our experience of the time interval to recurrence of DFSP.
DESIGN: A retrospective review was undertaken to identify patients with DFSP in our university teaching hospital.
METHODS: All patients received their primary surgical treatment in our department between February 1968 and June 2001. Treatment consisted of wide local excision with margins of at least 3 cm. The chi-square test and Fisher's exact test were performed to determine the relationship between recurrence and clinicopathological variables. We evaluated the prognostic variables using the Kaplan-Meier method with log-rank comparison.
RESULTS: The median follow-up period was 59 months. The 5 and 10-year disease-free survival (DFS) were 86 and 76%, respectively. The overall recurrence rate was 16.7%. The mean time to recurrence was 38+/-12 months (range 1-100 months). In 30% of those patients with recurrences, the local regional recurrence was after 5 years.
CONCLUSION: Wide local excision with good margins decreases local regional recurrences in patients with DFSP. Close surveillance is necessary even beyond 5 years because late recurrences occur.

Entities:  

Mesh:

Year:  2004        PMID: 15028319     DOI: 10.1016/j.ejso.2003.12.005

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  40 in total

Review 1.  Targeted therapy for dermatofibrosarcoma protuberans.

Authors:  Thomas A Abrams; Scott M Schuetze
Journal:  Curr Oncol Rep       Date:  2006-07       Impact factor: 5.075

2.  PDGFB Rearrangements in Dermatofibrosarcoma Protuberans of the Vulva: A Study of 11 Cases Including Myxoid and Fibrosarcomatous Variants.

Authors:  Khadijeh Jahanseir; Deyin Xing; Patricia T Greipp; William R Sukov; Gary L Keeney; Brooke E Howitt; J Kenneth Schoolmeester
Journal:  Int J Gynecol Pathol       Date:  2018-11       Impact factor: 2.762

3.  Dermatofibrosarcoma protuberans: a case report and review of the literature.

Authors:  D Paramythiotis; G Stavrou; D Panagiotou; G Petrakis; A Michalopoulos
Journal:  Hippokratia       Date:  2016 Jan-Mar       Impact factor: 0.471

4.  Dermatofibrosarcoma protuberans: Our experience of 59 cases.

Authors:  Alessio Stivala; Giuseppe A G Lombardo; Gianluca Pompili; Maria Stella Tarico; Filippo Fraggetta; Rosario Emanuele Perrotta
Journal:  Oncol Lett       Date:  2012-08-30       Impact factor: 2.967

5.  Dermatofibrosarcoma Protuberans: A Rare Malignancy of the Breast.

Authors:  Salim Al-Rahbi; Taha Al-Lawati; Suad Al-Kharusi; Sosamma Thomas; Khoula Al-Harrasi
Journal:  Oman Med J       Date:  2015-09

6.  Magnetic resonance imaging and mammographic appearance of dermatofibrosarcoma protuberans in a male breast: a case report and literature review.

Authors:  Xin Chen; Yung Hsin Chen; Yi-Li Zhang; You-Min Guo; Zhi-Lan Bai; Xian Zhao
Journal:  J Med Case Rep       Date:  2009-06-16

7.  Intracranial recurrence and distant metastasis of scalp dermatofibrosarcoma protuberans.

Authors:  Jurica Marakovic; Milorad Vilendecic; Tonko Marinovic; Smiljka Lambasa; Gordan Grahovac
Journal:  J Neurooncol       Date:  2008-03-15       Impact factor: 4.130

8.  Late local recurrence of dermatofibrosarcoma protuberans in the skin of female breast.

Authors:  Dimitrios M Dragoumis; Leda-Aikaterini K Katsohi; Ioannis K Amplianitis; Aris P Tsiftsoglou
Journal:  World J Surg Oncol       Date:  2010-06-03       Impact factor: 2.754

9.  Sunitinib for patients with locally advanced or distantly metastatic dermatofibrosarcoma protuberans but resistant to imatinib.

Authors:  Yan Fu; Huanrong Kang; Hui Zhao; Jia Hu; Huanhuan Zhang; Xiaosong Li; Nan Du; Yitao Huang
Journal:  Int J Clin Exp Med       Date:  2015-05-15

Review 10.  Current treatment options in dermatofibrosarcoma protuberans.

Authors:  Doreen Lemm; L-O Mügge; T Mentzel; K Höffken
Journal:  J Cancer Res Clin Oncol       Date:  2009-02-10       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.